| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/23/2007 | US20070196883 Enzyme |
| 08/23/2007 | US20070196857 Determination of risk and treatment of complications of prematurity |
| 08/23/2007 | US20070196445 Method for the Prevention and Treatment of Cachexia and Anorexia |
| 08/23/2007 | US20070196394 Immunogenic compositions comprising Liver Stage Malarial Antigens |
| 08/23/2007 | US20070196385 Method of treating hepatitis C infection |
| 08/23/2007 | US20070196370 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/23/2007 | US20070196332 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/23/2007 | DE102006008772A1 Hydroxymatairesinol gegen trockene Haut Hydroxymatairesinol dry skin |
| 08/23/2007 | CA2642850A1 Combination of alpha-2 receptor agonist (clonidine)and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea |
| 08/23/2007 | CA2641216A1 Fixed-dose association of phytate and zinc |
| 08/23/2007 | CA2641106A1 Skin-whitening cosmetic |
| 08/22/2007 | EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof |
| 08/22/2007 | EP1820805A2 Inhibitor and stimulator of haemotopoietic stem cell proliferation and uses thereof |
| 08/22/2007 | EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2007 | EP1820500A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 08/22/2007 | EP1819676A2 5-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists |
| 08/22/2007 | EP1572892A4 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 08/22/2007 | EP1513538A4 Novel methods for the delivery of polynucleotides to cells |
| 08/22/2007 | EP1499320B1 Novel compounds |
| 08/22/2007 | EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 08/22/2007 | EP1467970B1 Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors |
| 08/22/2007 | EP1467728B1 Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 08/22/2007 | EP1453804B1 Ccr-3 receptor antagonists vii |
| 08/22/2007 | EP1448523B1 Heterocyclic compounds and methods of use |
| 08/22/2007 | EP1379513B1 Prodrugs of cox-2 inhibitors |
| 08/22/2007 | EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS |
| 08/22/2007 | EP1183256B1 Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 08/22/2007 | EP1157040B1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 08/22/2007 | EP1150970B1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 08/22/2007 | EP1124824B1 Chromenone and chromanone derivatives as integrin inhibitors |
| 08/22/2007 | EP1124568B1 Polyspecific binding molecules and uses thereof |
| 08/22/2007 | EP0773950B1 Linked peptide nucleic acids |
| 08/22/2007 | CN1332974C Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use |
| 08/22/2007 | CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 08/22/2007 | CN1332954C Dipeptidyl peptidase IV effectors |
| 08/22/2007 | CN1332714C Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist |
| 08/22/2007 | CN1332713C Methods for inhibiting brain tumor growth |
| 08/22/2007 | CN1332711C Method for administering GLP-1 molecules |
| 08/22/2007 | CN1332698C Medicinal composition for removing fire and nourishing yin |
| 08/22/2007 | CN101023103A Virus-like particles comprising a fusion protein of the coat protein of ap205 and an antigenic polypeptide |
| 08/22/2007 | CN101020007A Medicine composition for treating college entrance examination syndrome and its use |
| 08/22/2007 | CN101019888A Medicine for treating fatty liver and alcoholic hepatitis and reducing blood fat and transaminase |
| 08/22/2007 | CN101019863A Application of 2-phenyl-1, 2-benzoisoselenazole-3(2H)-tone in preparing medicine for resisting sports fatigue |
| 08/22/2007 | CN101019836A Nanometer cytochrome liposome medicine and its prepn |
| 08/22/2007 | CN101019645A Health food for remitting fatigue and raising hypoxia tolerance and its prepn |
| 08/22/2007 | CN101019612A Orally taken health product for eliminating fatigue of racing pigeon |
| 08/22/2007 | CN101019589A Tea granule preparing process |
| 08/21/2007 | US7259271 [4-(tert-butyldimethylsilanyloxy)-3-oxobutyl]methylcarbamic acid tert-butyl ester; (R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-amine; for the treatment of cardiovascular disorders such as hypertension and chronic heart failure |
| 08/21/2007 | US7259243 Process for isolation of osteopontin from milk |
| 08/21/2007 | US7259188 Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators |
| 08/21/2007 | US7259187 Tropolone derivatives |
| 08/21/2007 | US7259181 β crystalline form of perindopril tert-butylamine salt |
| 08/21/2007 | US7259179 Kinase inhibitors |
| 08/21/2007 | US7259175 Alkanoic acids substituted with a group containing pyridinyl-, pyrimidinyl- or pyrazinyl-phenyl linked through a thiazolyl- or oxazolyl- phenyl group; e.g., 3-[4-(2-{2-[6-(2-Fluoro-phenyl)-pyridin-3-yl]-5-methyl-thiazol-4-yl}-ethoxy)-2-methyl-phenyl]-propionic acid; treating diabetes and atherosclerosis |
| 08/21/2007 | US7259168 2-Aminoalkyl-thieno[2,3-d]pyrimidines |
| 08/21/2007 | US7259159 Vitronectin receptor antagonists for treating and preventing osteoporosis, bone disorders |
| 08/21/2007 | US7259154 Pyrrolopyrimidines |
| 08/21/2007 | US7258973 Oligonucleotide sequences for use in the diagnosis and treatment of colon cancer |
| 08/21/2007 | US7258861 Peptides derived from the region of human TNF- alpha from Ser100 to Glu116 to treat pulmonary oedema. |
| 08/21/2007 | CA2493885C Use of sodium channel blocking compounds and aspirin in manufacturing drugs for producing synergistically analgesic effect in mammals |
| 08/21/2007 | CA2328730C Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein |
| 08/21/2007 | CA2315827C Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 08/21/2007 | CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders |
| 08/21/2007 | CA2294036C Polyallylamine polymers for treating hypercholesterolemia |
| 08/21/2007 | CA2257579C Genistein as a preventive against ultraviolet induced skin photodamage and cancer |
| 08/21/2007 | CA2150940C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 08/16/2007 | WO2007092829A2 Stabilized compositions of proteins having a free thiol moiety |
| 08/16/2007 | WO2007092469A2 Combination of organic compounds |
| 08/16/2007 | WO2007092161A2 A direct cellular energy delivery system |
| 08/16/2007 | WO2007091719A1 Concomitant anti-gpvi antibody therapy and novel medicinal use thereof |
| 08/16/2007 | WO2007091681A1 Radiotherapy enhancing agent in radiotherapy for tumor |
| 08/16/2007 | WO2007091623A1 Pharmaceutical composition comprising meglitinide for prevention of hepatic fibrosis |
| 08/16/2007 | WO2007091622A1 Anti-cancer pharmaceutical composition |
| 08/16/2007 | WO2007091613A1 Prophylactic or therapeutic agent for alzheimer's disease, and food/beverage |
| 08/16/2007 | WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate |
| 08/16/2007 | WO2007091501A1 Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease |
| 08/16/2007 | WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same |
| 08/16/2007 | WO2007090911A1 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof |
| 08/16/2007 | WO2007074291A3 Incontinence treatment methods |
| 08/16/2007 | WO2006124753A3 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 08/16/2007 | WO2003031404A3 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 08/16/2007 | US20070191495 Lipase inhibitor |
| 08/16/2007 | US20070191458 Preparing an anhydrous crystal of a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide by reacting the acid and amine in a solvent and crystallizing under various process conditions |
| 08/16/2007 | US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning |
| 08/16/2007 | US20070191402 Method of searching substrate having antidiabetic activity |
| 08/16/2007 | US20070191392 Dipeptide nitrile cathespin k inhibitors |
| 08/16/2007 | US20070191386 Bicyclo-pyrazole compounds specially pyrrolo[3,4-c]pyrazole or tetrahydropyridine[4,3-c]pyrazole derivatives; anticarcinogenic agents; N-{5-phenylacetyl-4,6-dihydropyrrolo[3,4-c]pyrazol-3-yl}phenylacetamide; modulators of apoptosis; combinatorial chemical library with an isocyanate polystyrenic resin |
| 08/16/2007 | US20070191380 Kinase inhibitor scaffolds and methods for their preparation |
| 08/16/2007 | US20070191347 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 08/16/2007 | US20070191328 Isoquinoline compounds |
| 08/16/2007 | US20070191299 Extension Of The Expression of Transgenic Proteins By Immunomodulation |
| 08/16/2007 | US20070191289 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 08/16/2007 | US20070191278 Cd8 as an inhibitor of the cellular immune system |
| 08/16/2007 | US20070191265 Anti-HIV Agent |
| 08/16/2007 | US20070191260 Novel indole derivative for alkylating specific base sequence of dna and alkylating agent and drug containing the derivative |
| 08/16/2007 | US20070190652 Anti-HIV Agent |
| 08/16/2007 | US20070190576 Mitogenic oxygenase regulators |
| 08/16/2007 | US20070190567 Treatment for asthma and allergy |
| 08/16/2007 | US20070190561 Nucleotide sequences coding polymerase for use in identifying modulators to treat cell proliferative disorders; enzyme inhibitors; antitumor agents |